| 摘要 |
The present invention relates to a peptide of Formula I, or a pharmaceutically acceptable salt thereof: X-P Formula I wherein: P is a DPPIV peptide metabolite of regulatory peptides obtained by cleavage of the two N-terminal amino acids; and X is defined by Formula II: wherein: A is selected from the group consisting of C1-C10 alkylene, C2-C10 alkenylene, C2-C10 alkynylene, C1-C10 heteroalkylene, C2-C10 heteroalkenylene, C2-C10 heteroalkynylene and phenyl; and B is selected from the group consisting of aryl, substituted aryl, heteroaryl, substituted heteroaryl and C3-C7 cycloalkyl.
|
